Portfolio Investor Building a Cross-Regional Platform

A healthcare-focused investor held several medtech assets across Europe and Asia, each operating in silos. The firms lacked a unified strategy to enter the US or other stringent regulated markets. As due diligence teams began focusing more heavily on global scale potential and regulatory robustness, the investor needed a partner to turn fragmented expansion attempts into a coherent, value-creating plan.

Without coordination, portfolio companies were duplicating regulatory efforts, selecting distributors opportunistically, and entering suboptimal markets that offered limited reimbursement or volume. The risk: under-realized synergies, slower exits, and lower portfolio IRR.

Distributor Principles engaged at the portfolio level. We conducted a cross-asset market and access feasibility review, identifying where US entry, EU expansion, or select emerging markets would create the strongest value. We standardized distributor qualification frameworks, contract templates, and regulatory roadmaps, tailored to each asset’s risk profile and class.

The result: a structured multi-year, multi-asset expansion roadmap as global scalability and compliance strength became core features of the platform story.